Global Practice Variation in the Management of Clostridioides difficile Infections: An International Cross-Sectional Survey of Clinicians - Summary - MDSpire
To evaluate global practice variability in the diagnosis, treatment, and prophylaxis of Clostridioides difficile infections (CDIs) among healthcare professionals, focusing on specific management aspects.
Key Findings:
75.8% of respondents used a 2-step CDI diagnostic algorithm, with variability in assay types indicating a need for standardization.
Significant differences were observed in first-line treatment agents for uncomplicated CDI, highlighting a lack of consensus on fulminant CDI management.
Secondary CDI prophylaxis was most common in North America (84.1%), contrasting with Europe (31.0%) and other continents (50.0%; P < .001), suggesting regional practice disparities.
Oral vancomycin was the most frequently used treatment (96.3%), with variability in dosing (125–500 mg daily) and duration (1–28 days; P < .01), indicating a need for clearer guidelines.
Interpretation:
The findings indicate substantial global variability in CDI management practices, likely due to conflicting guidelines and insufficient evidence, underscoring the need for further research to inform clinical practice.
Limitations:
Survey responses may not fully represent all healthcare professionals managing CDIs globally, potentially limiting the generalizability of the findings.
Potential biases in self-reported practices and limited response rates from certain regions may affect the reliability of the data.
Conclusion:
There is a critical need for randomized controlled trials to establish harmonized international best practices for CDI management, addressing the identified variability.
The expert panel outlines surveillance, device management, and diagnostic stewardship strategies to address both catheter-associated and non–catheter-associated infections.
Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.
